Mariagrazia Distefano Selected Research

Mariagrazia Distefano Research Topics

9	Ovarian Neoplasms (Ovarian Cancer) 05/2023 - 07/2003
9	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 03/2002
6	Neoplasms (Cancer) 05/2023 - 02/2002
3	Carcinoma (Carcinomatosis) 11/2006 - 03/2002
2	Ovarian Epithelial Carcinoma 01/2022 - 01/2020
1	Thrombosis (Thrombus) 05/2023
1	COVID-19 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Infections 01/2021
1	Anemia 11/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2003
1	Leukopenia 03/2002

5	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 03/2002
4	PlatinumIBA 01/2022 - 01/2017
3	Bevacizumab (Avastin)FDA Link 10/2021 - 01/2020
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 04/2007
2	Cisplatin (Platino)FDA LinkGeneric 03/2002 - 02/2002
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	TrabectedinIBA 01/2017
1	liposomal doxorubicin (Doxil)FDA Link 01/2017
1	1-dodecylpyridoxal (PLD)IBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2007
1	TubulinIBA 02/2007
1	hemoglobin ASIBA 11/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 07/2003
1	Antineoplastic Agents (Antineoplastics)IBA 03/2003
1	DNA (Deoxyribonucleic Acid)IBA 03/2003
1	taxaneIBA 03/2003
1	Taxoids (Taxanes)IBA 03/2003
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2002
1	Epirubicin (Ellence)FDA LinkGeneric 03/2002
1	FlavonoidsIBA 02/2002
1	IdB 1016IBA 02/2002
1	Silybin (Lagosa)IBA 02/2002

5	Drug Therapy (Chemotherapy) 05/2023 - 05/2005
5	Neoadjuvant Therapy 01/2022 - 03/2002
4	Chemoradiotherapy 10/2008 - 01/2004
2	Therapeutics 10/2021 - 03/2003
1	Catheters 05/2023
1	Cytoreduction Surgical Procedures 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Continuity of Patient Care 01/2021
1	Adjuvant Chemotherapy 01/2019
1	Lymph Node Excision (Lymph Node Dissection) 12/2017
1	Salvage Therapy 12/2014